Kevin Sayer has served as Chief Financial Officer of Biosensors International Group, Ltd., and as President of Biosensors International USA, a medical technology company developing, manufacturing and commercializing medical devices used in interventional cardiology and critical care procedures. Prior to joining Biosensors International Group, Mr. Sayer served as an independent healthcare and medical
technology industry consultant. From 2004 to 2005, Mr. Sayer was Executive Vice President and Chief Financial Officer of Specialty Laboratories, Inc., a company offering clinical reference laboratory services. Mr. Sayer also served as Chief Financial Officer of MiniMed, Inc., a medical technology company focused on insulin pumps for people with diabetes, from May 1994 until its acquisition by Medtronic, Inc. in
August 2001. Mr. Sayer is a Certified Public Accountant and received his Master's Degree in Accounting and Information system concurrently with a Bachelor's Degree in Accounting, both from Brigham Young University.